Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH
Background:. Immune cell–driven inflammation is a key mediator of metabolic dysfunction–associated steatohepatitis (MASH) progression. We have previously demonstrated that pharmacological sphingosine 1-phosphate (S1P) receptor modulation ameliorates MASH and is associated with attenuated accumulatio...
Saved in:
Main Authors: | Gopanandan Parthasarathy, Nanditha Venkatesan, Guneet Singh Sidhu, Myeong Jun Song, Chieh-Yu Liao, Fanta Barrow, Amy Mauer, Tejasav Sehrawat, Yasuhiko Nakao, P. Vineeth Daniel, Debanjali Dasgupta, Kevin Pavelko, Xavier S. Revelo, Harmeet Malhi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2025-02-01
|
Series: | Hepatology Communications |
Online Access: | http://journals.lww.com/10.1097/HC9.0000000000000613 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy
by: Lin Wang, et al.
Published: (2025-02-01) -
Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)
by: Zobair M. Younossi, et al.
Published: (2025-03-01) -
Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer
by: Junko Tsuchida, et al.
Published: (2017-01-01) -
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
by: Huanyu Z. Li, et al.
Published: (2025-01-01) -
Signal Transduction of Sphingosine-1-Phosphate G Protein—Coupled Receptors
by: Nicholas Young, et al.
Published: (2006-01-01)